Herbal Medicine Raw Material Manufacturing, Human

The national foreign-ownership ceiling for this activity is 0% — Perpres 10/2021 as amended by 49/2021 reserves it for domestic capital (Lampiran III entry #5), presumed to carry over from the KBLI 2020 code this one renamed (UU 17/2023; no contrary OSS/BKPM guidance found). In Bali, it is classified as medium-high to high risk, so it is not blocked by the local moratorium, but the PT PMA route itself is unavailable nationwide; you will need to secure a suitable industrial address and navigate additional licensing steps based on the risk level—verification per location is required.